NASDAQ
AHCO
Last Price
US $5.7
KEY FIGURES
MKT CAP
$0.8B
EPS
TTM
$-1.68
EPS Growth (1Y)
-185.25%
PEG
TTM
N/M
P/E
TTM
N/M
P/S
TTM
0.26x
YIELD
-
GROWTH (5Y CAGR)
Revenue
25.16%
EBITDA
Cash Flow (DCF)
Fair Value
Market $5.7
114.39%
Default assumptions
EBITDA Multiple
Fair Value
Market $5.7
123.16%
Default assumptions
Valuation
Financial
Performance
Cash flow to debt coverage
AdaptHealth Corp. cash flow to debt ratio of 31.63% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.
Free cash flow growth
AdaptHealth Corp.'s free cash flow has decreased 6.96% from $235.78M last year to $219.38M, signaling decreasing performance
Debt-to-equity ratio
AdaptHealth Corp.'s debt to equity ratio is 1.50, which means that the company's assets are unhealthy financed, signaling financial risk.
Debt-to-equity trend
AdaptHealth Corp.'s debt has increased relative to shareholder equity from 1.36 last year to 1.50 today, signaling weakened financials
Net debt to EBITDA
AdaptHealth Corp. has a net debt to EBITDA ratio of 3.57x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk
Interest coverage
AdaptHealth Corp.'s interest coverage ratio is -0.09, which means that the company struggles to meet interest obligations, signaling financial risk.
Profit margin growth
AdaptHealth Corp.'s profit margin has decreased (373.54%) in the last year from 2.77% to -7.58%, signaling decreasing performance
Current ratio
AdaptHealth Corp.'s short-term assets of $728.90M exceed its short-term liabilities of $712.39M
Return on assets
AdaptHealth Corp.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
AdaptHealth Corp.'s return on equity of -15.16%, is lower than 15.00%, indicating bad performance
Earnings quality
AdaptHealth Corp.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Earnings stability
AdaptHealth Corp. had positive net income in 3 out of 5 years, indicating stable and consistent earnings
Positive free cash flow
AdaptHealth Corp. has positive free cash flow, indicating the company generates cash after capital expenditures
Free cash flow yield
AdaptHealth Corp. has a free cash flow yield of 30.89%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Earnings growth
AdaptHealth Corp.'s yearly earnings has decreased 178.29% since last year from $90.42M to $-70.79M, signaling decreasing performance
Revenue growth
AdaptHealth Corp.'s yearly revenue has decreased 0.49% since last year from $3.26B to $3.24B, signaling decreasing performance
Return on invested capital
ROIC -0.24% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
3-year revenue CAGR
AdaptHealth Corp.'s 3-year revenue CAGR of 2.99% is positive, indicating growing revenue over the past 3 years
Revenue consistency
AdaptHealth Corp. had revenue growth in 4 out of 5 years, indicating consistent revenue performance
Return on equity consistency
AdaptHealth Corp. had positive ROE in 3 out of 5 years, indicating consistent and reliable returns on equity
Cash Flow Valuation (DCF)
AdaptHealth Corp. is undervalued relative to its fair value price of 12.22 based on Discounted Cash Flow model
Earnings yield (TTM)
AdaptHealth Corp. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
EBITDA Valuation
AdaptHealth Corp. is undervalued relative to its fair value price of 12.72 based on EBITDA multiple model
EV/EBITDA (FY)
AdaptHealth Corp. has an EV/EBITDA ratio of 4.98x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
PEG ratio (TTM/FY)
AdaptHealth Corp. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Price-to-book ratio (FY)
AdaptHealth Corp. has a price-to-book ratio of 0.51x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Price-to-sales ratio (TTM)
AdaptHealth Corp. has a price-to-sales ratio of 0.24x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-15.16%
Return on equity
ROIC: -0.24%
Valuation History
-
Price to Earnings
EV/EBITDA: 9.7X
Cash flow
Profit margin
-
Cash flow
7.07%
Base valuations use default assumptions. Customize in the Valuator.